Search the Site

Twitter

test tubes

$CEMI Chembio Diagnostics: FDA and CE Mark Decisions Expected by Year-End

publication date: Dec 10, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Written by Mike Havrilla--Chembio Diagnostics (CEMI) specializes in the development, manufacture and commercialization of rapid diagnostic tests for infectious disease that are designed for use at the point of care.


Sorry this page is available to subscribers only. If you're not a subscriber why not join today?

If you are already a subscriber, please login.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site including:

- Detailed Reports on Upcoming FDA and Clinical Trial Trades
- REAL TIME Posting of Trades (Entries and Exits)
- Clinical and Regualtory Catalyst Database with over 300 events and updated daily 
- Members Only Live Interactive Webinars 
- Live Chat Room 
- Video Lessons / Trade Reviews
- Chart / Technical Analysis 
- Run-Up Valuation Studies
- Weekly Watchlist Newsletter
- Email / SMS (Text Message) Alerts of critical news
- Access to view Mark Messier and Mike Havrilla's Trading Accounts
- A More Detailed FDA Calendar
- Historical FDA Tracker
- Bio-Pharma, FDA, Clinical Trials, and Stock Market News Updates
- Direct Email Communication
- Affiliate Program

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.